Good things keep happening to Questcor in the middle of the month. Here’s what’s notable: The middle of the month just happens to be the time that the company’s chief executive, Don M. Bailey, sells stock through his regular selling plan. …
Questcor (QCOR) Issues Response to StreetSweeper Report/Allegations Article Stock Quotes (1) Comments (0) FREE Breaking News Alerts from StreetInsider.com! E-mail Address
The 16% price increase comes on the news that Questcor is being acquired by an Irish specialty-pharmaceutical company, Mallinckrodt, in a deal worth $5.6 billion in cash and stock. It is worth noting, as always in these cases, that …
Of this amount, $0.6 million, during the second quarter, and $1.8 million, during the six month period, were related to the Company's Employee Stock Purchase Plan (ESPP). In February 2008, Questcor's Board of Directors approved a …
As a result of defendants’ false statements, Questcor’s stock traded at artificially inflated prices during the Class …
In a report published Tuesday, Mizuho Securities USA analyst Mario Corso reiterated a Buy rating and $93.00 price target on Questcor Pharmaceuticals (NASDAQ: QCOR). In the report, Mizuho Securities USA noted, “In the wake of today's …
Questcor’s shares were trading at $77 on the Nasdaq on Monday afternoon. Mallinckrodt was down 6 percent at $58.50 on the New York Stock Exchange. The deal - the latest in a series of acquisitions structured to take advantage of Ireland’s …
Questcor shareholders will receive $30.00 per share in cash and 0.897 Mallinckrodt shares for each share of Questcor common stock they own, for a total approximate consideration of $86.10 per Questcor share. Following completion of …
Questcor Announces Third Quarter 2009 Results November 02, 2009 16:05 ET | Source: Questcor Pharmaceuticals Sales for the treatment of multiple sclerosis up 14% sequentially Sales for the treatment of infantile spasms down 26% …
Questcor’s shares were trading at $77 on the Nasdaq on Monday afternoon. Mallinckrodt was down 6 percent at $58.50 on the New York Stock Exchange. The deal - the latest in a series of acquisitions structured to take advantage of Ireland’s …